These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38483407)

  • 1. Hemolysis impairs sickle cell erythropoiesis.
    Noguchi CT
    Blood; 2024 Mar; 143(11):947-949. PubMed ID: 38483407
    [No Abstract]   [Full Text] [Related]  

  • 2. Inflammation, Hemolysis, and Erythropoiesis Lead to Competitive Regulation of Hepcidin and Possibly Systemic Iron Status in Sickle Cell Disease.
    Ginzburg YZ; Glassberg J
    EBioMedicine; 2018 Aug; 34():8-9. PubMed ID: 30076048
    [No Abstract]   [Full Text] [Related]  

  • 3. The sickle cell hemolytic transfusion reaction syndrome.
    Petz LD; Calhoun L; Shulman IA; Johnson C; Herron RM
    Transfusion; 1997 Apr; 37(4):382-92. PubMed ID: 9111275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth differentiation factor-15 in young sickle cell disease patients: relation to hemolysis, iron overload and vascular complications.
    Tantawy AA; Adly AA; Ismail EA; Darwish YW; Ali Zedan M
    Blood Cells Mol Dis; 2014 Dec; 53(4):189-93. PubMed ID: 25065856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic hyper-hemolysis in sickle cell anemia: association of vascular complications and mortality with less frequent vasoocclusive pain.
    Taylor JG; Nolan VG; Mendelsohn L; Kato GJ; Gladwin MT; Steinberg MH
    PLoS One; 2008 May; 3(5):e2095. PubMed ID: 18461136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [On the pathogenesis of anemia in myeloma].
    BARBEC V; FRIEDMANN B; SEBESTIK V; BROUSIL J
    Z Gesamte Inn Med; 1963 Jun; 18():508-11. PubMed ID: 13966500
    [No Abstract]   [Full Text] [Related]  

  • 7. Massive hemolysis during sickle cell crisis.
    Parker DL; Parker JM; Stoltzfus GB
    Ohio State Med J; 1969 May; 65(5):495-6. PubMed ID: 4891298
    [No Abstract]   [Full Text] [Related]  

  • 8. The critically ill child: sickle cell disease crises and their management.
    Pearson HA; Diamond LK
    Pediatrics; 1971 Oct; 48(4):629-35. PubMed ID: 4940005
    [No Abstract]   [Full Text] [Related]  

  • 9. Vasculature and kidney complications in sickle cell disease.
    Nath KA; Katusic ZS
    J Am Soc Nephrol; 2012 May; 23(5):781-4. PubMed ID: 22440903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology of sickle cell anemia.
    Bookchin RM; Lew VL
    Hematol Oncol Clin North Am; 1996 Dec; 10(6):1241-53. PubMed ID: 8956013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperhemolytic transfusion reaction in sickle cell disease.
    Win N; Doughty H; Telfer P; Wild BJ; Pearson TC
    Transfusion; 2001 Mar; 41(3):323-8. PubMed ID: 11274584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sickle cell anemia-associated pulmonary arterial hypertension.
    Machado RF
    J Bras Pneumol; 2007; 33(5):583-91. PubMed ID: 18026658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heme-mediated cell activation: the inflammatory puzzle of sickle cell anemia.
    Guarda CCD; Santiago RP; Fiuza LM; Aleluia MM; Ferreira JRD; Figueiredo CVB; Yahouedehou SCMA; Oliveira RM; Lyra IM; Gonçalves MS
    Expert Rev Hematol; 2017 Jun; 10(6):533-541. PubMed ID: 28482712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease.
    Kato GJ; McGowan V; Machado RF; Little JA; Taylor J; Morris CR; Nichols JS; Wang X; Poljakovic M; Morris SM; Gladwin MT
    Blood; 2006 Mar; 107(6):2279-85. PubMed ID: 16291595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiopulmonary complications of sickle cell disease: role of nitric oxide and hemolytic anemia.
    Gladwin MT; Kato GJ
    Hematology Am Soc Hematol Educ Program; 2005; ():51-7. PubMed ID: 16304359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemolysis-associated priapism in sickle cell disease.
    Nolan VG; Wyszynski DF; Farrer LA; Steinberg MH
    Blood; 2005 Nov; 106(9):3264-7. PubMed ID: 15985542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemolysis and hemolysis-related complications in females vs. males with sickle cell disease.
    Raslan R; Shah BN; Zhang X; Kanias T; Han J; Machado RF; Gladwin MT; Gordeuk VR; Saraf SL
    Am J Hematol; 2018 Nov; 93(11):E376-E380. PubMed ID: 30117177
    [No Abstract]   [Full Text] [Related]  

  • 18. Degree of anemia, indirect markers of hemolysis, and vascular complications of sickle cell disease in Africa.
    Dubert M; Elion J; Tolo A; Diallo DA; Diop S; Diagne I; Sanogo I; Belinga S; Guifo O; Wamba G; Ngo Sack F; Boidy K; Kamara I; Traore Y; Diakite CO; Gbonon V; Faye BF; Seck M; Deme Ly I; Chelo D; N'Guetta R; Diop IB; Gaye B; Jouven X; Ranque B
    Blood; 2017 Nov; 130(20):2215-2223. PubMed ID: 28931524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strong association between a new marker of hemolysis and glomerulopathy in sickle cell anemia.
    Maier-Redelsperger M; Lévy P; Lionnet F; Stankovic K; Haymann JP; Lefèvre G; Avellino V; Perol JP; Girot R; Elion J
    Blood Cells Mol Dis; 2010 Dec; 45(4):289-92. PubMed ID: 20833087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COping with acute sickle cell hemolysis.
    Chonat S; Stowell SR
    Blood; 2024 Jun; 143(24):2452-2453. PubMed ID: 38869921
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.